By
Aaron Nicodemus2025-02-13T15:50:00
With a six-month ban on enforcement of the Foreign Corrupt Practices Act (FCPA), compliance should retreat from fear-based messaging and instead focus on why ethical practices make good business sense, experts say.
President Donald Trump has ordered the Department of Justice (DOJ) to place a six-month pause on enforcement of the FCPA, saying the law has been “stretched beyond proper bounds” and “abused” under Democratic leadership.
In an executive order issued Monday, Trump said that “overexpansive and unpredictable FCPA enforcement” of what he called “routine business practices in other nations”–namely, practices involving bribery–“actively harms American economic competitiveness and, therefore, national security.”
2025-06-11T16:44:00Z By Aaron Nicodemus
The Department of Justice has ended its six-month FCPA enforcement pause, closed half its legacy bribery cases, and will now pursue foreign bribery probes aligned with President Donald Trump’s priorities.
2025-02-10T15:27:00Z By Rezaul Karim, CW guest columnist
The dark web has been depicted as a long-standing hub for crimes, where illegal activities such as drug dealing, financial fraud, weapon sales, murder for hire, stolen credit cards, and ransomware gags are easily accessible to the public.
2025-02-06T20:05:00Z By Aaron Nicodemus
The U.S. Department of Justice under new Attorney General Pam Bondi will de-emphasize white collar misconduct linked to bribes and foreign corruption, instead prioritizing corruption cases linked to human smuggling and the trafficking of narcotics and firearms.
2025-12-10T15:30:00Z By Neil Hodge
For the past decade, Europe has led in creating strong but flexible rules for data use and safe AI development. The EU’s new plans to simplify key data privacy and AI governance measures have received a mixed response.
2025-12-05T19:25:00Z By Oscar Gonzalez
The U.S. Securities and Exchange Commission’s (SEC) Division of Examinations released its 2026 examination priorities, which give companies a roadmap of areas of heightened risk and regulatory focus for next year.
2025-12-04T22:15:00Z By Ruth Prickett
Regulation is a matter of life and death in the pharmaceutical industry. Rules to combat practices that can kill have been in force for decades, but tech developments are rapidly creating new risks and focusing lawmakers’ attention on areas where some compliance teams may lack experience.
Site powered by Webvision Cloud